Acceptability of ENG-releasing subdermal implants among postpartum Brazilian young women during the COVID-19 pandemic

Autor(es)

Barbieri, Mariane Massaini ^[1] ; Herculano, Thuany Bento ^[1] ; Silva, Amanda Dantas ^[1] ; Bahamondes, Luis ^[1] ; Teatin Juliato, Cassia Raquel ^[1] ; Surita, Fernanda Garanhani ^[1]

Afiliação do(s) autor(es)

^[1] Univ Estadual Campinas, Dept Obstet & Gynecol, Fac Med Sci, Campinas, SP - Brazil

• Tipo de documento: Artigo Científico
• Fonte: International Journal of Gynecology & Obstetrics; v. 154, n. 1, p. 106-112, JUL 2021.
• Citações Web of Science: 2

Resumo

Objective To evaluate etonogestrel (ENG)-implant acceptance during the immediate postnatal period among adolescents and young women during the COVID-19 pandemic, and to compare variables according to choice and discuss possible implications of this measure during the pandemic period. Methods A cross-sectional study was designed. All women aged up to 24 years, who delivered between April 25, 2020, and June 24, 2020, at Women's Hospital, University of Campinas, Sao Paulo, Brazil were considered. The ENG-implant or other contraceptive methods were offered prior to hospital discharge. The participants were split into two groups: (1) those who chose the ENG-implant and (2) those that refused the implant. Descriptive, bivariate, and multivariate analyses were performed. Results 151 women were included, with 76.2% selecting the ENG-implant. The average age was 19.5 years; 73.2% of pregnancies were unplanned, 32.5% already had a previous pregnancy, 74% were single, and 75.5% were not in full time education. Further, 70.5% had previously used contraceptives, with 89.1% unsatisfied with their previous method that opted for the ENG-implant (P = 0.07). Conclusion Offering the ENG-implant to youths during the immediate postnatal period is evidence-based care, and contraceptive provision is an essential health promotion tool, even during a pandemic. Thinking quickly about public policies in times of crisis is important to guarantee sexual and reproductive rights. (AU)

• Processo FAPESP: 18/20868-9 - Implante subdérmico em puérperas adolescentes: ensaio clínico não-randomizado
• Beneficiário: Fernanda Garanhani de Castro Surita
• Modalidade de apoio: Auxílio à Pesquisa - Regular